Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1980 1
1982 1
1983 3
1984 2
1987 4
1988 1
1989 5
1990 4
1991 3
1992 4
1993 5
1994 3
1995 4
1996 8
1997 8
1998 9
1999 5
2000 2
2001 10
2002 3
2003 12
2004 8
2005 10
2006 9
2007 7
2008 10
2009 10
2010 26
2011 13
2012 10
2013 8
2014 9
2015 10
2016 13
2017 14
2018 11
2019 14
2020 14
2021 11
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18472366

289 results

Results by year

Filters applied: . Clear all
Page 1
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D; National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group. Glynne-Jones R, et al. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):119-26. doi: 10.1016/j.ijrobp.2007.12.012. Epub 2008 May 9. Int J Radiat Oncol Biol Phys. 2008. PMID: 18472366 Clinical Trial.
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort.
Jones CM, Adams R, Downing A, Glynne-Jones R, Harrison M, Hawkins M, Sebag-Montefiore D, Gilbert DC, Muirhead R. Jones CM, et al. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1202-1211. doi: 10.1016/j.ijrobp.2018.04.033. Epub 2018 Apr 19. Int J Radiat Oncol Biol Phys. 2018. PMID: 29859793 Free article.
Capecitabine With Mitomycin Reduces Acute Hematologic Toxicity and Treatment Delays in Patients Undergoing Definitive Chemoradiation Using Intensity Modulated Radiation Therapy for Anal Cancer.
Goodman KA, Julie D, Cercek A, Cambridge L, Woo KM, Zhang Z, Wu AJ, Reidy DL, Segal NH, Stadler ZK, Saltz LB. Goodman KA, et al. Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1087-1095. doi: 10.1016/j.ijrobp.2017.03.022. Epub 2017 Mar 22. Int J Radiat Oncol Biol Phys. 2017. PMID: 28721892
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
Matzinger O, Roelofsen F, Mineur L, Koswig S, Van Der Steen-Banasik EM, Van Houtte P, Haustermans K, Radosevic-Jelic L, Mueller RP, Maingon P, Collette L, Bosset JF; EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups. Matzinger O, et al. Eur J Cancer. 2009 Nov;45(16):2782-91. doi: 10.1016/j.ejca.2009.06.020. Epub 2009 Jul 28. Eur J Cancer. 2009. PMID: 19643599 Clinical Trial.
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K. Flam M, et al. J Clin Oncol. 1996 Sep;14(9):2527-39. doi: 10.1200/JCO.1996.14.9.2527. J Clin Oncol. 1996. PMID: 8823332 Clinical Trial.
289 results